Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse

The detection of prostate cancer recurrence after external beam radiotherapy relies on the measurement of a sustained rise of serum prostate-specific antigen (PSA). However, this biochemical relapse may take years to occur, thereby delaying the delivery of a secondary treatment to patients with recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzo, Guillermo, di Muzio, Nadia, Deantoni, Chiara Lucrezia, Cozzarini, Cesare, Fodor, Andrei, Briganti, Alberto, Montorsi, Francesco, Pérez-García, Víctor M., Gomez, Hector, Reali, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641236/
https://www.ncbi.nlm.nih.gov/pubmed/36388979
http://dx.doi.org/10.1016/j.isci.2022.105430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641236/
https://www.ncbi.nlm.nih.gov/pubmed/36388979
http://dx.doi.org/10.1016/j.isci.2022.105430

Ejemplares similares